HER2-positive Newly Diagnosed, Primary Breast Cancer
1 clinical trials · Condition
◉ Watch HER2-positive Newly Diagnosed, Primary Breast Cancer
| Record | Firm | Date |
|---|---|---|
| NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer (NCT01816594) | Novartis Pharmaceuticals | 2013-09-03 |
Track HER2-positive Newly Diagnosed, Primary Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.